WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...

WASHINGTON – On April 22, 2023, DEA and its law enforcement partners came together once again to protect our communities from prescription misuse by safely disposing of 663,725 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s bi-annual National Prescription Take...

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

WASHINGTON – DEA is proud to join “Song for Charlie” and many of our valued law enforcement, public health, and non-profit partners in recognizing National Fentanyl Awareness Day. Tomorrow represents an important opportunity to remember the victims of fentanyl poisoning and educate people in our communities about the deadly threat...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced the results of a year-long national operation, “Operation Last Mile,” targeting operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels responsible for the last mile of fentanyl and methamphetamine distribution on our streets and on social media. DEA’s top...

WASHINGTON, DC – The Drug Enforcement Administration will host its 24th National Prescription Drug Take Back Day on Saturday, April 22, from 10 a.m. to 2 p.m. This event offers anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. For more than a decade, Take Back...

WASHINGTON – Today, the Drug Enforcement Administration released the final report of the Foreign Operations Review Team, which contains recommendations to improve the effectiveness and enhance the integrity of DEA’s foreign operations. In August 2021, DEA requested this comprehensive review, which was led by Jack Lawn, a former DEA Administrator...

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...

WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...